BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17476756)

  • 1. [The stratification treatment that was based on a prognostic factor of malignant lymphoma].
    Niitsu N
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():534-9. PubMed ID: 17476756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of cytostatic therapy of malignant hemoblastoses].
    Stacher A
    Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
    [No Abstract]   [Full Text] [Related]  

  • 3. Bleomycin in the treatment of the advanced, resistant and recurrent lymphomata.
    Garrett MJ; Smith JD
    Ir Med J; 1976 Feb; 69(3):67-70. PubMed ID: 67107
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of the lymphomas.
    Lacher MJ
    Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
    Dreyling M
    Dtsch Med Wochenschr; 2011 Apr; 136(14):687-90. PubMed ID: 21448827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory endoxan therapy by high doses].
    Fischer M; Martin H; Schubert JC
    Dtsch Med Wochenschr; 1967 Jun; 92(25):1145-50. PubMed ID: 5338225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
    Satoh T; Tsushima K; Hizawa Y; Nakui Y; Itoh J; Tamura Y; Saitoh S; Taka-mi H; Munakata A; Kawamura S
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):733-6. PubMed ID: 9126313
    [No Abstract]   [Full Text] [Related]  

  • 8. Present management of the lymphomas.
    Kabakow B
    Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():39-45. PubMed ID: 4950557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma.
    Papoudou-Bai A; Marinos L; Papathanasiou K; Kanavaros P; Kapsali E
    Turk J Haematol; 2018 Nov; 35(4):308-309. PubMed ID: 30398157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methylhydrazine in the therapy of malignant lymphopathies].
    Beltrametti L; Almici C
    Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of piposulfan (ancyte) in malignant lymphomas and solid tumors].
    Kenis Y
    Acta Clin Belg; 1968; 23(2):103-13. PubMed ID: 4914032
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of malignant lymphoma with procarbazine].
    Matsumoto N; Oyama H; Matsumura M; Suetsugu N; Abe S
    Rinsho Ketsueki; 1972 Oct; 13(5):820-6. PubMed ID: 4566539
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
    Girinsky T; Lapusan S; Ribrag V; Koscielny S; Ferme C; Carde P
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):476-9. PubMed ID: 15667970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The choice of second-line chemotherapy for malignant lymphoma].
    Ikeda T; Hotta T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):6-10. PubMed ID: 15675573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard treatment of advanced-stage diffuse large B-cell lymphoma.
    Coiffier B
    Semin Hematol; 2006 Oct; 43(4):213-20. PubMed ID: 17027655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.